Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

November 30, 2014

Conditions
SchizophreniaSchizophrenic DisorderHyperprolactinemiaHyperprolactinaemia
Interventions
DRUG

PGD granules

The preparation of Peony-Glycyrrhiza Decoction (PGD) granules is in compliance with Pharmacopoeia of the People's Republic of China and Good Manufacturing Practice (GMP). Briefly, sliced, broiled Paeoniae Alba Radix and Glycyrrhizae Radix in a ratio of 1:1 in weight will be immersed and boiled in an 8-fold volume of distilled water for 2.5 hours. This process will be repeated twice. The extract solution will be pooled and concentrated into granule form. Weight of the resulting granules contained in two 9g-sachet packs (to be taken in one day) is equivalent to 45 g raw herbal materials which are supplied for one day.

DRUG

Placebo

The placebo granules are prepared to be identical to PGD granules in smell, taste and color.

Trial Locations (4)

100088

Beijing Anding Hospital, Beijing

710032

Xijing Hospital, Xian

Unknown

Department of Psychiatry, Queen Mary Hospital, Hong Kong

Department of Psychiatry, Kowloon Hospital, Kowloon

All Listed Sponsors
collaborator

Kowloon Hospital, Hong Kong

OTHER

collaborator

Queen Mary Hospital, Hong Kong

OTHER

collaborator

Capital Medical University

OTHER

collaborator

Xijing Hospital

OTHER

lead

The University of Hong Kong

OTHER

NCT01852331 - Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter